The Multipurpose Arthritis Center (MAC) of the University of Alabama in Birmingham (UAB) is Multidisciplinary effort by faculty and staff of the Schools of Medicine, Dentistry, Nursing, Public Health, and Community and Allied Health, and the University Hospitals and Clinics. A broad spectrum of ongoing and proposed activities is focused on basic and clinical research, education, community activities, and health services research. Research in MAC includes studies in the areas of immunology, virology, mycoplasmology, molecular biology, genetics, connective tissue biochemistry, and clinical rheumatology. The Education Component spans the spectrum of professional, allied health, postgraduate and public and patient educational activities. The Community and HEalth Services Research Component highlights socio-economic factors that influence the well-being of patients with rheumatic disease. This application includes feasibility proposals in fundamental research from seven investigators to study basic mechanisms involved in the pathogenesis of the rheumatic diseases. Five new projects are proposed in patient and professional education. Six projects are proposed in the Community and Health Services Research Component, and include critical evaluation analyses applicable to this important area. In addition, three Core Units are proposed - continuation of the Hybridoma Core Facility, and development of a new Immunogenetics Core and a new Evaluation, Biostatistics and Data Management Core Unit. The overall goals are to coordinate existing arthritis programs and initiate new programs in arthritis so that we can achieve 1) greater knowledge of the etiologies, pathogeneses and therapies of the rheumatic diseases 2) better systems of health education 3) documentation of current and improvement of future patient services and 4) a more enlightened community attitude toward arthritis.

Project Start
1977-09-20
Project End
1986-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
8
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Qin, Hongwei; Niyongere, Sandrine A; Lee, Sun Jung et al. (2008) Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J Immunol 181:3167-76
Lee, Sun Jung; Qin, Hongwei; Benveniste, Etty N (2007) Simvastatin inhibits IFN-gamma-induced CD40 gene expression by suppressing STAT-1alpha. J Leukoc Biol 82:436-47
Qin, Hongwei; Wilson, Cynthia A; Lee, Sun Jung et al. (2006) IFN-beta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. FASEB J 20:985-7
Dong, Y; Tang, L; Letterio, J J et al. (2001) The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J Immunol 167:311-9
Rohn, W; Tang, L P; Dong, Y et al. (1999) IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. J Immunol 162:886-96
Lee, Y J; Benveniste, E N (1996) Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. J Immunol 157:1559-68
Reveille, J D; Suarez Almazor, M E; Russell, A S et al. (1994) HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis? Semin Arthritis Rheum 23:295-309
Zheng, X; Watson, H L; Waites, K B et al. (1992) Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates. Infect Immun 60:3472-4
Vidovic, M; Sparacio, S M; Elovitz, M et al. (1990) Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha. J Neuroimmunol 30:189-200
Lorish, C D; Richards, B; Brown Jr, S (1990) Perspective of the patient with rheumatoid arthritis on issues related to missed medication. Arthritis Care Res 3:78-84

Showing the most recent 10 out of 40 publications